Some patients may experience different patterns of side effects with less frequent dosing, but there is insufficient evidence to predict individual responses to modified schedules
This allows for more gradual dose adjustments to minimize side effects and optimize weight loss outcomes
Our team addresses these alongside medication for a holistic approach
depemokimab SC Manufacturer: GlaxoSmithKline Proposed indications Add-on maintenance treatment of asthma with type 2 inflammation characterized by an eosinophilic phenotype in patients aged 12 years Add-on maintenance treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) in adults Clinical overview Mechanism of action Depemokimab is an ultra-long-acting monoclonal antibody (mAb) that targets IL-5, a key cytokine in type 2 inflammation
Clinical studies have shown correlations between elevated TNF- levels and impaired sperm motility and fertilization potential [307, 308]
But also when we put people on such a significant caloric deficit, that also starts to have negative impact on their hormones, like their thyroid